SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS
DEAD

Serial Number

86035910

Owner

ASTRAZENECA AB

Attorney

Marc Stanislawczyk

Filing Date

Aug 12, 2013

Add to watchlist:

No watchlists yet
View on USPTO

SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS Trademark

Serial Number: 86035910

SAVOR - SAXAGLIPTIN ASSESSMENT OF VASCULAR OUTCOMES RECORDED IN PATIENTS WITH DIABETES MELLITUS is a trademark filed by ASTRAZENECA AB on August 12, 2013. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ASTRAZENECA AB (1,109 trademarks)

VASTRA MALAREHAMNEN 9
SODERTALJE SE-151 85 , SE

Entity Type: 03

BRISTOL-MYERS SQUIBB COMPANY (4,814 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

August 12, 2013

Registration Date

Not Registered

Goods & Services

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 8, 2014 ASCK
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 7, 2014 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 5, 2014 ABN2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 19, 2014 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 18, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 18, 2014 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 21, 2013 GNRN
NON-FINAL ACTION E-MAILED
Nov 21, 2013 GNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2013 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2013 NWOS
NEW APPLICATION ENTERED
Aug 15, 2013 NWAP